Ashwin K A Kamath

View Scopus Profile

Phone+91-9844262808
Emailashwin.kamathmanipaledu
Websitehttps://manipal.edu/kmc-mangalore/department-faculty/faculty-list/ashwin-kamath-k-anandaraya.html

h-index

Research activity per year

Research Interests

Pharmacology

External positions

Fingerprint

Dive into the research topics where Ashwin K A Kamath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

75 Article
8 Letter
8 Review article
1 Chapter

Comment on ‘comparative effectiveness of clopidogrel vs. potent P2Y₁₂ inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study’
Shaik, M. R. & Kamath, A., 2026, (Accepted/In press) In: British Journal of Clinical Pharmacology.
Research output: Contribution to journal › Letter › peer-review

Open Access
Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
GBD 2023 Substance Use Collaborators, 02-2026, In: Nature Medicine. 32, 2, p. 527-544 18 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Link opens in a new tab Citation (Scopus)
Adverse Events of 4% Articaine in Children below 4 Years of Age: An Observational Study
Ananthu, H., Rao, A. P., Kamath, A., Rao, S. T. & Natarajan, S., 11-2025, In: International Journal of Clinical Pediatric Dentistry. 18, 11, p. 1322-1326 5 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
GBD 2019 Acute and Chronic Care Collaborators, 12-2025, In: Nature Communications. 16, 1, 4235.
Research output: Contribution to journal › Article › peer-review

Open Access
Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review
Bharathi Rajaduraivelpandian, P., Rao, R. R. & Kamath, A., 12-2025, In: Medical sciences. 13, 4, 327.
Research output: Contribution to journal › Article › peer-review

Open Access

Ashwin K A Kamath

Personal profile

Research Interests

External positions

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Comment on ‘comparative effectiveness of clopidogrel vs. potent P2Y₁₂ inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study’

Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study

Adverse Events of 4% Articaine in Children below 4 Years of Age: An Observational Study

Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review

Ashwin K A Kamath

Personal profile

Research Interests

External positions

Fingerprint

Collaborations and top research areas from the last five years

Research output

Comment on ‘comparative effectiveness of clopidogrel vs. potent P2Y12 inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study’

Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study

Adverse Events of 4% Articaine in Children below 4 Years of Age: An Observational Study

Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review

Comment on ‘comparative effectiveness of clopidogrel vs. potent P2Y₁₂ inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study’